Article
Effect of Calcium Dobesilate (CaD) on Diabetic Macular Edema Treated by Intravitreal Ranibizumab
2021-08-31
Abstract excerpt
<h4>Background: </h4> Calcium dobesilate (CaD) had been used in the treatment of diabetic retinopathy (DR) due to its potential in protecting against retinal vascular damage. However, it did not reduce the risk of development of diabetic macular edema (DME). The aim of this study was to investigate the effect of CaD plus intravitreal ranibizumab in the treatment of DME. <h4>Methods: </h4>: This retrospective, obse...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bfd6fcb4-7608-5f16-ab3e-6e29fd293a1f
- DOI
- 10.21203/rs.3.rs-830956/v1
